Stephenson Brian C

Chief Financial OfficerFaeth Therapeutics, Inc. (FTH) · full profile →Form 4 · filed Jun 24, 2026
Net Buying
Open-Market Buys
$406K
Open-Market Sells
$0
Net Open-Market Flow
$406K
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2026Buy(P)7K$24.12$165K15K
Jun 23, 2026Buy(P)2K$24.84$49K17K
Jun 23, 2026Buy(P)425$25.91$11K17K
Jun 22, 2026Buy(P)3K$23.28$77K8K
Jun 22, 2026Buy(P)2K$20.23$36K2K
Jun 22, 2026Buy(P)356$23.95$9K8K
Jun 22, 2026Buy(P)1K$20.82$23K3K
Jun 22, 2026Buy(P)2K$22.40$35K4K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780030-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about FTH insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001780030-26-000004"
Ask your agent
Use Arkolith to summarize insider buying and selling at Faeth Therapeutics, Inc.
over the last 90 days and cite the filings.